Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.35 |
| ▸ | NR1D1 | P20393 | 5/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 2/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16558068 | 0.93 | CA12 (0.39) | CA12CA1CA7CA14CA9 | |
| SCHEMBL26035583 | 0.90 | CA12 (0.40) | CA12CA1CA7CA14CA2 | |
| SCHEMBL16558064 | 0.89 | DNM1 (0.39) | CA12CA1CA7CA14CTSK | |
| SCHEMBL16558063 | 0.88 | CA12 (0.36) | CA12CA1CA7CA14CA2 | |
| SCHEMBL19458 | 0.87 | TDP1 (0.42) | CA12CA1CA7CA14CA2 | |
| SCHEMBL18752992 | 0.87 | CA14 (0.39) | CA12CA1CA7CA14NR1I3 | |
| SCHEMBL7567930 | 0.85 | CA12 (0.37) | CA12CA1CA7CA14CA9 | |
| SCHEMBL27420033 | 0.84 | NR1D1 (0.38) | CA12CA1CA7CA14CA2 | |
| SCHEMBL7567960 | 0.84 | CHRM2 (0.37) | CA12CA1CA7CA14NR1D1 | |
| SCHEMBL8777347 | 0.83 | CA1 (0.35) | CA12CA1CA7CA14CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10994016-B2 | Graphene oxide mediated cellular delivery of gadolinium-labeled molecules | NORTHWESTERN UNIVERSITY (US) | 2021-05-04 | — | — | US | disclosed |
| US-20170074859-A1 | Graphene Oxide Cellular Delivery of Hydrophilic Small Molecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-03-16 | — | — | US | disclosed |
| US-20040072785-A1 | Intravascular delivery of non-viral nucleic acid | WOLFF JON A (US) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10994016-B2 | Graphene oxide mediated cellular delivery of gadolinium-labeled molecules | GZMB, GCG, GLMN | CA12 455/4885CA1 370/4885CA7 1031/4885 |
| US-20170074859-A1 | Graphene Oxide Cellular Delivery of Hydrophilic Small Molecules | CD44, EPCAM, VIM | CA12 2759/4885CA1 4064/4885CA7 4346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.